[UK] Pharmaceutical Products (CPV Codes 33660000-4, 33620000-2, 33650000-1)

This tender, from the Communal Enterprise "Lubny Hospital of Intensive Care" of the Lubny City Council, concerns the procurement of essential pharmaceutical products. The tender explicitly states that the country of origin for the goods cannot be the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran, a condition confirmed by the bidder's submission in accordance with Ukrainian Cabinet of Ministers Resolution No. 822. The specified items include Metamizole Sodium solution for injection (500 mg/ml, 2 ml), Furosemide solution for injection (10 mg/ml, 2 ml), and Fluconazole tablets/capsules (50 mg). These medications fall under various CPV codes: 33660000-4 (Nervous system drugs), 33620000-2 (Blood, blood-forming organs, and cardiovascular system drugs), and 33650000-1 (General anti-infectives for systemic use, vaccines, antineoplastics, and immunomodulators). The procuring entity, a hospital, requires these medications for patient treatment. The exclusion of specific countries of origin reflects current geopolitical circumstances and national security policies. The tender seeks qualified pharmaceutical suppliers to provide these vital medicines, ensuring the continuity of medical care at the Lubny Hospital.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 145,410.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.